Simon Tate

Insider Reports History

Location
Redmond, WA
Signature
/s/ William Cowles, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Simon Tate:

Company Role Class Num Shares Value Price $ Report Date Ownership
Eliem Therapeutics, Inc. Director Stock Option (Right To Buy) 10,000 26 Jun 2024 Direct

Insider Reports Filed by Simon Tate

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CLYM Eliem Therapeutics, Inc. 26 Jun 2024 1 $0 4 Director 28 Jun 2024, 17:13
CLYM Eliem Therapeutics, Inc. 18 May 2023 1 $0 4 Director 22 May 2023, 17:13
CLYM Eliem Therapeutics, Inc. 19 May 2022 1 $0 4 Director 01 Jun 2022, 17:17
CLYM Eliem Therapeutics, Inc. 09 Aug 2021 1 $0 4 Director 11 Aug 2021, 17:17
CLYM Eliem Therapeutics, Inc. 09 Aug 2021 0 $0 3 Director 09 Aug 2021, 18:18
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .